Skip to content

REGENTIS BIOMATERIALS LTD.

RGNT

CIK 0001912966 · Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE

← back to feed
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
−$13.65M
−384.3% YoY FY Dec 2025
EPS Diluted (TTM)
−$24.16
−1,504.7% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
$7.38M
FY Dec 2025
Total Debt
$1.2M
FY Dec 2025
Shares Outstanding
5.18M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings